Ligand Pharmaceuticals Incorporated (LGND) stock analysis

In our weekly check, Ligand Pharmaceuticals Incorporated is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 13 pass, warnings: 4, red flags: 6.

About Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as LGND.

What our checks show for LGND

Red flags

Warning signs

Strengths

Similar companies

MIRM · IBRX · CAI · BLTE · CGON · ARWR

Questions

What grade does Ligand Pharmaceuticals Incorporated (LGND) have?

In our weekly check, Ligand Pharmaceuticals Incorporated is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 13 pass, warnings: 4, red flags: 6. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of LGND stock?

This week's biggest flags for Ligand Pharmaceuticals Incorporated: High debt, High P/E, Deep past fall. In total 10 of 23 checks show a warning or a red flag.

What does Ligand Pharmaceuticals Incorporated do?

Ligand Pharmaceuticals Incorporated is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as LGND.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis